SRC
BDSI

Shufro Rose & Co’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Shufro Rose & Co’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,200
Closed -$56K – 269
2015
Q3 		$56K Hold
10,200
– – 0.01% 252
2015
Q2 		$81K Buy
+10,200
New +$87.6K 0.01% 248

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Shufro Rose & Co's BDSI Position: Q4 2015 in Review

Shufro Rose & Co sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2015, closing a stake of 10,200 shares — an estimated $56K sold.

Shufro Rose & Co first reported a position in BDSI in Q2 2015 and held it in 2 quarters. The position peaked at $81K in Q2 2015. 126 funds tracked by Wall St. Rank hold BDSI as of Q4 2015.

  • Shufro Rose & Co reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2015 after selling out during the quarter.
  • Shufro Rose & Co sold 10,200 BioDelivery Sciences International, Inc. shares in Q4 2015, an estimated $56K.
  • Shufro Rose & Co first reported a position in BioDelivery Sciences International, Inc. in Q2 2015 and held it in 2 quarters.
  • Shufro Rose & Co's BioDelivery Sciences International, Inc. position peaked at $81K in Q2 2015.
  • 126 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2015.

Based on Shufro Rose & Co's 13F filing for Q4 2015, filed 15 Jan 2016.